A previous study reported that high levels of CRP increased the risk of cardiovascular events and mortality34; thus, both unfavorable metabolic parameters and systemic inflammation might be associated with higher comorbidity and mortality in non‐obese NAFLD.8, 9. The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.